We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Capsugel Completes Acquisitions of Xcelience and Powdersize

News   Jan 07, 2016

 
Capsugel Completes Acquisitions of Xcelience and Powdersize
 
 
Advertisement
 

RELATED ARTICLES

Drug That Targets Challenging Cancer Mutation Could Treat Several Tumor Types

News

A new clinical trial shows a novel drug designed to counter the effects of an important cancer mutation could be effective against a range of tumor types including lung and gynecological cancers.

READ MORE

Trial Will Investigate if Anti-Nausea Drug Can Alleviate Hallucinations in People With Parkinson's

News

Phase 2 clinical trial will explore if the drug ondansetron is safe and effective against hallucinations in patients with Parkinson's disease.

READ MORE

Investigational Drug Safely Slows Progression of Diabetic Kidney Disease in Clinical Trial

News

Patients with diabetic kidney disease could potentially be treated with an investigational new drug that may slow the progress of their illness without harmful adverse effects to their hearts, according to the results of a recent global clinical trial.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE